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Autoantibodies against double-stranded DNA (anti-dsDNA) are a hallmark of systemic 
lupus erythematosus (SLE). It is well documented that anti-dsDNA reactive B lympho-
cytes are normally controlled by immune self-tolerance mechanisms operating at several 
levels. The evolution of high levels of IgG anti-dsDNA in SLE is dependent on somatic 
hypermutation and clonal selection, presumably in germinal centers from non-autoreac-
tive B cells. Twin studies as well as genetic studies in mice indicate a very strong genetic 
contribution for the development of anti-dsDNA as well as SLE. Only few single gene 
defects with a monogenic Mendelian inheritance have been described so far that are 
directly responsible for the development of anti-dsDNA and SLE. Recently, among other 
mutations, rare null-alleles for the deoxyribonuclease 1 like 3 (DNASE1L3) and the Fc 
gamma receptor IIB (FCGR2B) have been described in SLE patients and genetic mouse 
models. Here, we demonstrate that double Dnase1l3- and FcgR2b-deficient mice in 
the C57BL/6 background exhibit a very early and massive IgG anti-dsDNA production. 
Already at 10 weeks of age, autoantibody production in double-deficient mice exceeds 
autoantibody levels of diseased 9-month-old NZB/W mice, a long established multigenic 
SLE mouse model. In single gene-deficient mice, autoantibody levels were moderately 
elevated at early age of the mice. Premature autoantibody production was accompanied 
by a spontaneous hyperactivation of germinal centers, early expansions of T follicular 
helper cells, and elevated plasmablasts in the spleen. Anti-dsDNA hybridomas gener-
ated from double-deficient mice show significantly elevated numbers of arginines in the 
CDR3 regions of the heavy-chain as well as clonal expansions and diversification of 
B cell clones with moderate numbers of somatic mutations. Our findings show a strong 
epistatic interaction of two SLE-alleles which prevent early and high-level anti-dsDNA 
autoantibody production. Both genes apparently synergize to keep in check excessive 
germinal center reactions evolving into IgG anti-dsDNA antibody producing B cells.
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inTrODUcTiOn
The formation of antibodies against DNA is considered to be 
the serologic hallmark of systemic lupus erythematosus (SLE). 
Autoantibodies against double-stranded DNA (anti-dsDNA) 
antibodies are the most studied and the most enigmatic autoan-
tibodies in SLE. Their presence correlates with nephritis both in 
human SLE patients and in mice with a spontaneous lupus-like 
disease (1–3).
Systemic lupus erythematosus has a strong genetic component 
as demonstrated by high concordance rates for disease manifesta-
tion as well as autoantibody development in monozygotic twins 
(4, 5). In rare cases, a monogenic cause for the development of SLE-
like disease and autoantibody production illustrates the pathways 
that predispose for SLE. The strongest associations were found to 
loss of function of genes that are involved in clearance of apoptotic 
cells, chromatin, and nucleic acids (6). Homozygous mutations in 
the C1q genes are responsible for SLE or SLE-like disease (7) and 
C1q-deficient mice accumulate apoptotic cells in several tissues and 
develop anti-DNA autoantibodies and SLE in certain genetic back-
grounds but not in the C57BL/6 background (8, 9). Homozygous 
mutations in the TREX1 gene encoding a DNA exonuclease pre-
sent in the cytoplasm are associated with the Aicardi–Goutieres 
syndrome-1 with increased systemic type I interferon levels and 
antinuclear autoantibodies (10). Likewise, Trex1-deficient mice 
develop autoantibodies and SLE-like disease.
Other apparently monogenic causes of SLE-like disease and 
anti-DNA autoantibodies were described in mutant mice. The 
deficiency of the IgG inhibitory Fc γ receptor IIB (FcγRIIB) is 
associated with the development of SLE in mice with a strong 
influence of background genes, however (11, 12). In the absence 
of FcγRIIB, autoreactive B cells are found in the germinal centers 
and somatic hypermutation contributed to anti-DNA reactivity 
(13). In mice, a promoter variant in the Fcgr2b gene results in 
enhanced germinal center responses and autoantibody produc-
tion (14). A defunctioning single nucleotide polymorphism 
(SNP) in the human FCGR2B gene is associated with suscepti-
bility to SLE (15) and the upregulation of FcγRIIB in memory 
B  cells is decreased in SLE patients (16). In addition, FcγRIIB 
plays an important regulatory function on dendritic cells (DCs), 
macrophages, and neutrophils [reviewed in Ref. (17)].
Another single gene defect leading to anti-DNA production 
and SLE-like disease is demonstrated by the observation that milk 
fat globule-EGF factor 8 has a critical role in removing apoptotic 
B cells in the germinal centers and that its absence can lead to 
autoimmune diseases (18).
More recently, deficiency in the Deoxyribonuclease 1 like 3 gene 
(DNASE1L3) was associated with SLE-like disease in Arabian, 
Turkish, and Italian families (19–21). SLE-like symptoms were 
associated with a hypocomplementemic urticarial vasculitis 
syndrome in several clinical cases. In Dnase1l3-deficient mice, 
anti-dsDNA autoantibodies develop, followed by a late onset of 
SLE-like disease (22). Dnase1l3 is part of four homologous mam-
malian extracellular deoxyribonucleases of the Dnase1 family, 
Dnase1, Dnase1l1, Dnase1l2, and Dnase1l3 (23).
Here, we describe a new conditional mouse model for 
Dnase1l3 deficiency and confirm the early appearance of IgG 
anti-dsDNA autoantibodies at moderate levels in the serum of 
these mice. The development of anti-dsDNA antibodies does not 
require the presence of toll-like receptor 9 (TLR9) but a strong 
epistatic interaction with a mutation in the Fcgr2b gene leads to 
strikingly early and high anti-dsDNA serum levels accompanied 
by spontaneous hyperactivation of germinal centers.
MaTerials anD MeThODs
Mice
Mice were maintained in SPF conditions at the animal facility 
of the Friedrich-Alexander-University, Erlangen. C57BL/6 mice 
were obtained from Charles River, Sulzfeld, Germany. TLR9-
deficient mice (24) were a kind gift of H. Wagner, Munich. 
Fcgr2b-deficient mice (25) backcrossed for 12 generations to 
C57BL/6 were obtained from Taconic and the yaa mutation 
was introduced by breeding in the yaa mutation from male 
B6.SB-Yaa/J mice obtained from the Jackson laboratory. For the 
generation of Dnase1l3-deficient mice, a targeting vector was 
obtained from the KOMP consortium (project CSD48807, clone 
HTGRS01006_A_B09) and partially re-sequenced. Standard 
techniques were used to transfect the V6.5 embryonic stem 
cell line (kindly provided by R. Jaenisch, Boston) derived from 
a C57BL/6x129Sv F1 cross (26). Homologous recombination 
was screened with left arm and right arm primers by PCR using 
LongAmp® Taq (New England Biolabs) according to the instruc-
tions of the manufacturer. Primers are listed in the Primer List 
in Data Sheet S2 in Supplementary Material. Correct integration 
was further verified by sequencing of the PCR products from 
both sides of the genomic integration. ES cells were injected 
into C57BL/6 blastocysts and chimeric mice were crossed with 
C57BL/6 mice. After germline transmission, one line was kept 
on C57BL/6x129sv mixed background. A pure backcross to 
C57BL/6 background was obtained by marker-assisted speed-
congenics using 74 genomic SNP markers (LGC Genomics, 
KASP  genotyping) covering all mouse chromosomes. After 
five generations, heterozygous offspring mice containing all 
marker loci from C57BL/6 were intercrossed to obtain C57BL/6 
“knockout-first” Dnase1l3-deficient mice. After crossing with flp-
deleter mice (27), Dnase1l3-deficient mice with a deleted exon 2 
were created. For the establishment of Dnase1l3/Fcgr2b double-
deficient mice, male Fcgr2b−/− yaa mice were intercrossed with 
C57BL/6 “knockout-first” Dnase1l3-deficient mice. In the F2 
generation, homozygous Dnase1l3/Fcgr2b double-deficient male 
and female mice were selected and used for further breeding. 
Animal care and experiments were approved by the animal eth-
ics committee of Regierung von Mittelfranken (Animal Ethics 
Number: 54-2532.1-21/09 and TS-05/5).
Flow cytometric analysis
For cell sorting of macrophage and DC cell populations, spleen, 
liver, lung, brain, and lamina propria tissue from 8- to 14-week-old 
C57BL/6 mice was mechanically dissociated with a gentle MACS™ 
and the respective tissue dissociation kit (Miltenyi Biotec). Bone 
marrow cells were flushed from femurs of C57BL/6 mice. For 
analysis of germinal center cells and myeloid cells, spleens were 
harvested, crushed through a 100 µM nylon mesh filter and resus-
pended in RPMI 1640 medium (PAN-Biotech) supplemented with 
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10% FCS. After erythrocyte lysis (5 min at room temperature in 
0.15 M NH4Cl, 0.02 M HEPES, 0.1 mM EDTA), cells were washed 
two times and resuspended in FACS buffer (PBS, 2% FCS, 1 mM 
EDTA) for staining with directly conjugated antibodies. For intra-
cellular IFN-γ staining, cells were treated with Cell Stimulation 
Cocktail +  Protein Transport Inhibitors (eBioscience) for 2  h at 
37°C. Cells were stained extracellularly for TFH markers and were 
fixed and permeabilized with the FIX & PERM Kit (Nordic-
MUbio) according to the manufacturer’s protocol. The following 
antibody conjugates were obtained from BioLegend: CD45-BV421, 
CD19-BV421, CD38-PE, GL7-APC, CD95-PECy7, CD11b-BV510, 
CD11b-PECy7, CD11c-APCCy7, LY6C-PerCPCy5.5, LY6G-FITC, 
CXCR5-BV421, and PD1-PECy7. The following antibody con-
jugates were obtained from eBioscience: MHCII-PE, CD4-FITC, 
CD44-APC, CD8-FITC, B220-PerCPCy5.5, IgD-PE, IgM-FITC, 
CD21-FITC, CD23-PE, and F4/80-AF647. BV510-conjugated 
anti-PSGL-1 and BV421-conjugated anti-F4/80 were obtained 
from BD Biosciences. APC-conjugated anti-Siglec-H was obtained 
from Miltenyi Biotec. Flow cytometry analysis was performed on a 
Cytoflex instrument (Beckman Coulter) and FlowJo v10.4 analysis 
software (FlowJo, LLC).
elisa for anti-dsDna autoantibodies
Levels of anti-dsDNA were measured by ELISA. 20 µg/ml % poly-
l-lysine (Sigma-Aldrich) was used to precoat MaxiSorp plates 
(Nunc). After 2  h at RT, plates were coated with dsDNA from 
calf thymus (20  µg/ml; Sigma-Aldrich) in TE (pH 7.5) buffer 
overnight at 4°C. Plates were washed with PBS/0.05% Tween 20 
and sera was added in 1/2 serial dilutions starting at 1/100. A 
serum pool obtained from 9-month-old diseased NZB/W mice 
served as internal standard. The starting dilution of 1/200 of 
the NZB/W serum was arbitrarily assigned to 100 relative units. 
Goat-anti-mouse IgG or goat-anti-mouse IgM, Fc-specific, cou-
pled to horseradish peroxidase was used for detection (Jackson 
ImmunoResearch).
gene expression by Quantitative rT-Pcr 
(qrT-Pcr)
For qRT-PCR, RNA from FACS sorted cells was isolated by the 
RNeasy kit (QIAGEN) according to the manufacturer’s instruc-
tions. cDNA was synthesized by SCRIPTUM reverse transcriptase 
(Bio&Sell), and qRT-PCR was performed on a quantitative PCR 
system (Biorad CFX96) with Absolute qPCR SYBR Green Mix 2× 
(Thermo Scientific) using intron-spanning primers for Dnase1l3 
and HPRT (see Primer List in Data Sheet S2 in Supplementary 
Material). In a second set of experiments, TaqMan® Assays for 
Dnase1l3 and GAPDH were performed on an Applied Biosystems 
7500 machine. Calculation of relative expression levels were 
performed according to the relative ΔCt-method (28).
hybridoma Production and sequencing of 
V region genes
Hybridomas were generated from three female double-deficient 
mice that previously had a rise of IgG anti-dsDNA autoantibodies 
in the serum. As a fusion partner, SP2/0 cells obtained originally 
from F. Melchers, Basel were used. Standard techniques were 
applied and hybridoma supernatants were tested on day 10 after 
fusion for IgG anti-dsDNA antibodies by ELISA. Hybridoma cells 
from positive wells were expanded and subcloned by single cell 
sorting at least once.
Total RNA was isolated from the hybridomas with RNeasy 
(Qiagen) and variable genes of the hybridomas were cloned with 
RT-PCR using universal VH- and VL-primers (see Primer List in 
Data Sheet S2 in Supplementary Material) and the StrataClone 
PCR Cloning Kit. Inserts were Sanger sequenced with M13 
primers annealing to the plasmid vector (LGC Genomics). The 
analysis for VH and VL gene usage, CDR-assignment and for 
potential somatic mutations was performed by V-QUEST (29) 
at the IMGT website.1 Sequence alignment was created with the 
Geneious Software (Biomatters Ltd.).
resUlTs
expression of Dnase1l3 in hematopoietic 
cells
It was described that Dnase1l3 is primarily expressed in mac-
rophages in liver and spleen (30). To obtain a more detailed view 
of the expression pattern of Dnase1l3 in hematopoietic cells in 
different tissues, we isolated lymphocyte, monocyte, macrophage, 
and DC populations from blood, bone marrow, spleen, lymph 
node, peritoneal cavity, liver, lung, brain, and lamina propria of 
the colon by FACS sorting and analyzed expression of Dnase1l3 
by quantitative real-time PCR. The results are summarized in 
Table 1. Among lymphocytes, a low-level expression of Dnase1l3 
was found in B1a B  cells and marginal zone B  cells, whereas 
conventional B  cells as well as T  cells did show no detectable 
expression. We did not detect any expression of Dnase1l3 in 
different blood or tissue monocytes, including inflammatory 
monocytes from mice infected with the murine cytomegalovi-
rus. Also, granulocytes did not exhibit detectable expression. As 
described before (22), conventional DCs in the spleen but also in 
liver and lamina propria expressed the highest levels of Dnase1l3. 
Among tissue resident macrophages, we detected a more complex 
expression pattern. Red pulp macrophages from spleen, Kupffer 
cells from liver, as well as macrophages from the lamina propria 
expressed very high levels, whereas macrophages isolated from 
the bone marrow, the peritoneum, the brain (microglia), and 
lung (alveolar macrophages) showed no detectable expression. 
Lower levels were detected in subcapsular sinus macrophages as 
well as plasmacytoid DCs. In summary, we detected Dnase1l3 
expression mainly in antigen-presenting cell populations like 
conventional DCs and B1a and marginal zone B cells as well as in 
some tissue resident macrophages.
generation of conditional Dnase 
1l3-Deficient Mice
To study the physiological function of Dnase1l3, we generated 
Dnase1l3-deficient mice using the “knockout-first” strategy as 
described by Skarnes et al. (31). The knockout-first allele is ini-
tially a non-expressive form, but can be converted to a conditional 
allele after recombination with Flp recombinase (Figure S1A in 
1 www.imgt.org (Accessed: April, 2016–March, 2018).
TaBle 1 | Expression levels of Dnase1l3 in mouse hematopoietic cells.
cell population; organ Phenotype used for Facs sorting relative expression levelsa
Pre/pro B cells, bone marrow B220+ IgM− –
Immature B cells, bone marrow B220+ IgM+ IgD− –
Follicular B cells, spleen B220+ CD21lo CD23hi –
Marginal zone B cells, spleen B220+ CD21hi CD23lo +
B1a B cells, peritoneum B220+ CD11b+ CD5+ +
T cells, spleen B220− CD3+ –
Monocytes, non-classical, blood CD45+ CD11b+ Ly6C+ MHCIIlo –
Monocytes, classical, blood CD45+ CD11b+ Ly6C− MHCIIlo –
Monocytes, peritoneum CD45+ CD11bhi F4/80lo MHCII+ –
Monocytes, spleen CD45+ CD11b+ Ly6C+ MHCIIlo –
Monocytes, lung CD45+ CD11b+ LY6C+ MHCIIlo –
Monocytes, bone marrow CD45+ CD11b+ Ly6C+ MHCIIlo –
Monocytes, lung, mCMV infection CD45+ CD11b+ LY6C+ MHCII+ –
Neutr. granulocytes, bone marrow CD45+ Ly-6Ghi –
Plasmacytoid dendritic cells (DCs) CD45+ CD11clo SiglecH+ +
Myeloid DCs, spleen CD11c++ MHC++ CD11b+ CD8− +++
Lymphoid DCs, spleen CD11c++ MHC++ CD11b− CD8+ +++
DCs, liver CD11b+ CD11c+ Ly6C− MHCII++ ++
DCs, lamina propria colon CD11b+ CD11c+ Ly6C− MHCII++ +++
Microglia, brain CD45lo F4/80+ CD11b+ –
Macrophages, bone marrow CD45+ F4/80+ CD11blow CD11c− –
Macrophages, peritoneum CD45+ F4/80++ CD11b+ CD11clo –
Alveolar macrophages, lung CD45+ F4/80+ CD11blow CD11c++ –
Macrophages, spleen CD45+ F4/80+ CD11blow CD11c− +++
Kupffer cells, liver CD45+ F4/80+ CD11blow CD11c− +++
Macrophages, lamina propria colon CD45+ F4/80+ CD11blow CD11c− ++
Subcapsular sinus macrophages, LN CD11b+ CD169+ CD11c− F4/80− +
Relative expression levels as determined by quantitative real-time PCR from sorted cells. Summary of two to five individual experiments, each.
aRelative expression levels as compared to expression levels in spleen CD11chi DCs.
–, not detectable; +, 1–5% of DCs; ++, 5–20% of DCs; +++, 20–100% of DCs.
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Supplementary Material). Transcripts are forced to be spliced from 
exon 1 of the Dnase1l3 gene to the splice acceptor side of a lacZ 
reporter and terminated by the downstream polyA sides. This 
should result in a knockout allele, as downstream exons are not 
transcribed (Figures S1A,B in Supplementary Material). To verify 
that downstream exons are not transcribed from the knockout-
first allele [allele name termed Dnase1l3tm1a(KOMP)Wtsi according to 
Skarnes et al. (31), abbreviated as Dnase1l3tm1a], we used cDNA from 
MACS-enriched DCs from spleens of homozygous and littermate 
mice in an RT-PCR reaction using primers located in downstream 
exons 5 and 7 (Figure S1B in Supplementary Material). As shown 
in Figure S1C in Supplementary Material, transcripts from the 
mutated allele were undetectable by this sensitive PCR reaction. 
This shows that the knockout-first allele is a null allele, as expected 
from the analysis of many similar alleles generated by the KOMP 
program (32). We also crossed mice with the knockout-first allele 
with E2a-Cre deleter mice (33) to obtain an exon 2 knockout allele 
missing exon 2 which will be termed Dnase1l3Δex2.
Development of anti-dsDna 
autoantibodies in Dnase1l3-Deficient Mice
We analyzed serum IgG anti-dsDNA autoantibodies from 
groups of mice at different ages. As shown in Figure 1A, homozy-
gous Dnase1l3-deficient mice showed significantly elevated IgG 
anti-dsDNA antibody levels already at young age (3–4 months). 
At later time points (Figures  1B–D), these titers show only a 
moderate increase. Dnase1l3-deficient mice at 1-year of age still 
have significantly, but modestly increased IgG anti-dsDNA titers. 
All groups except group 4 in Figure 1B are derived from mice 
in a mixed 129 × C57BL/6 background. For the group of mice 
at the age of 18–26  weeks fully congenic C57BL/6 mice have 
similar anti-dsDNA antibody levels, suggesting that the mixed 
genetic background of the mice had little if any influence on 
the development of anti-dsDNA antibodies (Figure  1B). For a 
cohort of 16- to 28-week-old mice, the influence of the sex on the 
development of autoantibodies was analyzed. As shown in Figure 
S2 in Supplementary Material a tendency for higher anti-dsDNA 
autoantibodies in female versus male mice was observed, which 
was not statistically significant. In addition, we analyzed homozy-
gous Dnase1l3Δex2 mice with a complete deletion of exon 2 of 
Dnase1l3 and found similar levels of anti-dsDNA autoantibodies 
as compared to mice with a homozygous Dnase1l3tm1a mutation, 
further supporting the notion that Dnase1l3tm1a mutation is a 
null mutation (Figure 2A). Thus, Dnase1l3-deficient mice spon-
taneously develop moderate levels of anti-DNA autoantibodies 
already at 3-month of age which are not increasing significantly 
upon aging. Neither a significant contribution of residual 129 
genetic background nor any significant influence of the sex of the 
mice influenced anti-dsDNA autoantibodies.
FigUre 1 | Development of IgG autoantibodies against double-stranded DNA (anti-dsDNA) antibodies in Dnase1l3-deficient mice. Sera from mice at the age of  
(a) 12–16 weeks, (B) 18–26 weeks, (c) 26–38 weeks, and (D) 40–52 weeks were tested for IgG anti-dsDNA antibodies by ELISA. The mice are grouped according 
to the genotype of the Dnase1l3tm1a mutation. All cohorts of mice are derived from 129 × C57BL/6 mixed background except homozygous mutant mice in (B) which 
are backcrossed to pure C57BL/6 background (B6−/−). Relative binding units are presented as compared to a standard serum pool from 9-month-old NZB/W mice. 
The dotted lines represent a cutoff derived from a panel of sera from C57BL/6 mice. Data are presented as box plot with individual data represented by filled circles 
(*p < 0.05; **p < 0.01; ***p < 0.001 Mann–Whitney U test).
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epistatic interactions With Other 
Mutations involved in the generation  
of anti-dsDna antibodies
As anti-dsDNA autoantibody levels remained moderately 
elevated in Dnase1l3-deficient mice up to an age of 1  year, we 
asked the question whether other relevant single mutations might 
influence anti-dsDNA autoantibody titers. First, we intercrossed 
Dnase1l3-deficient mice with TLR9-deficient mice to obtain 
double-deficient mice. As demonstrated in Figure 2A, additional 
TLR9-deficiency had no significant influence on anti-dsDNA 
titers in Dnase1l3-deficient mice. We also generated double-
deficient mice for Dnase1l3 and Fcgr2b in which male mice in 
addition contain the yaa mutation accelerating SLE-like disease 
FigUre 2 | Development of IgG and IgM autoantibodies against double-stranded DNA (anti-dsDNA) antibodies in double-deficient mice. In (a), the results from  
3- to 4-month-old toll-like receptor 9 (TLR9) × Dnase1l3 mice are displayed. The genotypes of the mice are denoted at the axis. In (B), the results from 3-month-old 
FcgR2b × Dnase1l3 mice are displayed. The genotypes of the mice are denoted at the axis. The dotted lines represent anti-dsDNA antibody levels of a serum pool 
of 9-month-old female NZB/W mice. Data are presented as box plot with individual data represented by filled circles. (c) Follow-up of IgG anti-dsDNA autoantibody 
levels in individual female FcgR2b × Dnase1l3 double-deficient mice (red) and male FcgR2b yaa × Dnase1l3 double-deficient mice (blue). In (D), the IgM anti-dsDNA 
levels from a cohort of 2- to 3-month-old FcgR2b × Dnase1l3 mice are displayed. The genotypes of the mice are denoted at the axis. Data are presented as box 
plot with individual data represented by filled circles (*p < 0.05; **p < 0.01; ***p < 0.001 Mann–Whitney U test).
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in the FcγRIIB-deficient background (12). As shown in Figure 2B, 
we observed extremely high anti-dsDNA titers in double-
deficient male mice at the age of 3-month reaching anti-dsDNA 
levels similar to 9-month-old NZB/W female mice. At this age, 
FcγRIIB−/− yaa male mice had anti-dsDNA titers comparable to 
single Dnase1l3-deficient mice which were around 50-fold lower 
than in male double-deficient mice (Figure 2B).
Since these anti-dsDNA antibody levels in double-deficient 
male mice were higher than in any other SLE-prone strain of mice 
including MRL/lpr and NZB/W mice at the same age, we weekly 
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analyzed anti-dsDNA antibodies in sera starting at the age of 
7 weeks. We included also female mice in this analysis. As shown 
in Figure 2C, already at the age of 7 weeks all male mice (blue 
curves in Figure  2C) had clearly elevated anti-dsDNA serum 
levels that might have be transferred from the double-deficient 
mothers via placental transfer. We consider this unlikely, how-
ever, as some female littermate mice at the same age had normal 
levels of anti-dsDNA antibodies in their sera (Figure 2C). In all 
male mice of this cohort and in three out of six female mice which 
we analyzed at this young age, IgG anti-dsDNA antibody levels 
massively increased within 3–5 weeks up to 50-fold, reaching a 
maximum level around 10–12  weeks of age. Most of the other 
female mice developed these maximum levels of autoanti bodies 
at the age of 15–20 weeks. Thus, mutations in Dnase1l3 and Fcgr2b 
show strong epistasis and the yaa mutation further increases the 
penetrance of early hyperproduction of anti-dsDNA antibodies 
in male mice in this model.
As IgM anti-DNA autoantibodies typically develop early in 
SLE models, we analyzed IgM anti-dsDNA levels in a cohort of 
2- to 3-month-old animals of the different genotypes. Interestingly, 
Dnase1l3 single-deficient mice show highly elevated IgM anti-
dsDNA autoantibodies comparable to double-deficient mice, 
whereas FcγRIIB-knockout mice had normal IgM anti-dsDNA 
levels (Figure 2D). Thus, loss of tolerance toward DNA is an early 
event in Dnase1l3-deficient mice.
spontaneous germinal center Formation 
and elevated Production of anti-dsDna 
secreting cells in Dnase1l3 and FcγriiB 
Double-Deficient Mice
We have proposed earlier that anti-dsDNA antibodies evolve 
from non-autoreactive progenitors in germinal centers (34, 35) 
and strong evidence has been accumulated that the FcγRIIB plays 
an important role in B cell tolerance in the GC (17). We therefore 
analyzed spontaneous germinal center development in double-
deficient mice at the age of 9–14 weeks. As shown in Figure 3A, 
all male double-deficient mice had elevated frequencies of 
CD38lo, GL7+, Fas+ GC B cells in the spleen when compared to 
both single deficient male or female mice or wild-type C57BL/6 
mice. In this cohort, one out of five female double-deficient mice 
showed a dramatically elevated GC B cell frequency. Therefore, 
the early and strong anti-dsDNA antibody response is accompa-
nied by GC hyperactivation in double-deficient mice.
The activation of B cells in the spleens of double-deficient mice 
is also accompanied by high frequencies of IgG—antibody secret-
ing plasma blasts or plasma cells (Figure  3B). Up to 3% of all 
B cells were found to be IgG antibody secreting cells, suggesting 
a considerable hyperactivation of the B cell compartment. Only 
a fraction of these IgG secreting B cells was anti-dsDNA specific 
(0.6–3.8% of all IgG secreting cells, Figures 3B,C).
analysis of somatic hypermutation in igg 
anti-dsDna hybridomas
To gain further insight into the mechanism of anti-dsDNA 
development in double-deficient mice, we prepared hybridomas 
from spleens of unimmunized mice and selected IgG anti-dsDNA 
hybridomas for the sequence analysis of VH- and in selected case 
also VL-genes. For this analysis, we focused on female double-
deficient mice that were selected for previous rise of IgG anti-
dsDNA autoantibodies before fusion. Data for the VH-genes are 
summarized in Table 2. Most hybridoma clones used the IgG2c 
isotype (25/31 clones) followed by a few IgG2b and one IgG3 
anti-dsDNA hybridoma, similar to anti-DNA autoantibodies in 
other SLE-prone mice (36). In all three mice that were used for 
the generation of hybridomas we observed clonally related hybri-
domas clearly derived from one B cell and diversified by somatic 
mutations. We detected somatic mutations in the heavy chains of 
all hybridomas (Table 2; Figure S3 in Supplementary Material). 
In many cases, the numbers of mutations within the VH and VL 
gene region were relatively low with few replacement mutations 
present. For those clones that contributed with three or more 
individual hybridomas, we analyzed the diversification from the 
germline sequence as well as intraclonal diversification in more 
detail. Very few shared mutations were observed within the 
clonal relatives as shown in Figure S3 in Supplementary Material 
suggesting a “bush-like” diversification by somatic hypermuta-
tion from a single B cell rather than a stepwise maturation with 
intermediate selection.
We found that the CDR3 regions of the heavy chains of the 
hybridomas have an unusually high frequency of arginines, as it 
has been noted before in collections of anti-dsDNA hybridomas 
from SLE-prone mouse strains (39). Whereas 6,203 arginines can 
be found among 166,000 amino acids (3.7%) in the CDR3 region 
of mouse antibodies in the large abYsis antibody database,2 all 
anti-dsDNA hybridomas together described here have a fre-
quency of 16.2% (47 arginines among 289 CDR3 amino acids; 
p < 0.001, Chi-Square). Interestingly, we found a recurrent usage 
of one VH gene (VH5-17) among expanded clones in all three 
independent mice (shaded in Table  2). In summary, sequence 
analysis of anti-dsDNA hybridomas showed clear evidence for 
clonal expansion and somatic mutation among the anti-dsDNA 
hybridomas from double-deficient mice.
early expansion of T Follicular helper (TFh) 
cells in Dnase1l3 and FcγriiB Double-
Deficient Mice
To get some mechanistic insight into the early spontaneous 
formation of germinal centers, we analyzed cohorts of young 
(8–9 weeks of age) and older mice (14–19 weeks) of single- and 
double-knockout mice for myeloid cell populations as well 
as T helper cell subpopulations in the spleen. The analysis of 
the frequency of monocytes, DCs, plasmacytoid DCs, and 
macrophages in the spleen did not reveal significant changes 
among single- or double-mutant mice as compared to C57BL/6 
mice of similar age (data not shown). We observed an increase 
of Ly6G-positive neutrophils in the spleen of older FcγRIIB- as 
well as double-knockout mice, most likely reflecting inflamma-
tory activity (Figure 4A). General activation of the CD4+ T cell 
compartment as evidenced by high levels of CD44 expression 
was observed in older FcγRIIB- as well as in double-knockout 
2 http://www.bioinf.org.uk/abysis3.1 (Accessed: November 12, 2017).
FigUre 3 | Spontaneous germinal center development and elevated production of autoantibodies against double-stranded DNA (anti-dsDNA) secreting cells in 
Dnase1l3 and FcgR2b double-deficient mice. (a) Analysis of splenic B cells from 9- to 14-week-old mice by flow cytometry. The frequency of GL7+, Fas+ germinal 
center B cells among all CD19+ B cells is displayed. The frequency of total IgG (B) and IgG anti-dsDNA (c) secreting B cells was determined by Elispot. Blue circles 
represent male mice, red circles represent female mice; dotted line in (c) represents the limit of detection (*p < 0.05; Mann–Whitney U test).
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mice, but interestingly not in older Dnase1l3 single knockout 
animals (Figure  4B). Expansions of CD44hi TH cells were not 
observed in any cohort of young mice. T  cell hyperactivation 
was particularly high in male animals carrying the yaa allele as 
denoted by the blue symbols but not restricted to yaa-animals 
in the cohorts (Figure  4B). We observed an expansion of the 
PD1hi PSGL-1lo TFH cells in older FcγRIIB-knockout mice and 
particularly striking in double-knockout mice (Figure  4C). 
TaBle 2 | Summary of V region gene analysis from autoantibodies against double-stranded DNA hybridomas.
hybridoma clonea isotype Vh gene Jh gene Mutations: total/non-silent cDr3b number of arg in cDr3c
Mouse 1, female 14w
4B10.1 #1 IgG2c V5-17 J4 4/3 ARrKLrNYYAMDY 2
6B9.1 #1 IgG2c V5-17 J4 3/2 ARrKLrNYYAMDY 2
7F4.1 #2 IgG2b V1-82 J2 1/1 ARPGrrGrYYFDY 3
3C5.2 #2 IgG2c V1-82 J2 2/0 ARPGrrGrYYFDY 3
3F5.1 #3 IgG2c V1-7 J3 4/2 ARSYYGSKGWFTY 0
3E2.1 #4 IgG2c V1-26 J2 6/2 ASGDSSGPFDY 0
1E7.1 #5 IgG2c V2-2 J4 1/0 ARNrLrrGLDY 3
2B11.1 #6 IgG2c V1-81 J2 9/6 AGEHAGPYYFDY 0
10A12.1 #7 IgG2c V5-9-1 J3 5/3 TRGGDSSGYrFAY 1
Mouse 2, female 12w
1E5 #1 IgG2c V5-17 J4 1/1 ARrGLrGVMDY 2
8F4 #1 IgG2c V5-17 J4 7/5 VRrGLrGAMDY 2
8H4 #1 IgG2c V5-17 J4 4/1 VRrGLrGAMDY 2
1G2.1 #1 IgG2c V5-17 J4 4/3 ARrGLrGAMNY 2
2C1.2 #1 IgG2c V5-17 J4 4/2 VRrGLrGAMDY 2
4H2.1 #1 IgG2c V5-17 J4 2/0 ARrGLrGAMDY 2
5G3 #2 IgG2b V5-17 J4 6/4 AKQLrLrYYAMDY 2
6E5 #2 IgG2b V5-17 J4 4/3 SKQLrLrYYAMDY 2
9A10 #2 IgG2b V5-17 J4 6/5 AKQLrLrYYAMDY 2
3C5 #3 IgG2b V9-4 J4 1/1 ARDGNSYEGFAY 0
Mouse 3, female 24w
5G12 #1 IgG2c V1-81 J3 7/6 AEDGYAWFTY 0
5F11 #1 IgG2c V1-81 J3 4/4 AEDGYVWFAY 0
4C2 #1 IgG2c V1-81 J3 13/10 AEDGYVWFAY 0
3B7 #2 IgG2c V1-9 J3 9/4 ARErNYITGFAY 1
1F10 #2 IgG2c V1-9 J3 9/7 ARErNYITGFAY 1
1D12 #2 IgG2c V1-9 J3 2/1 ARErNYITGFAY 1
2A2 #3 IgG2c V7-3 J2 1/1 ARFPAGTrrYYFDY 2
5B4 #3 IgG2c V7-3 J2 4/2 ARFPAGTrrYYFDY 2
3A9 #3 IgG2c V7-3 J2 3/2 ARFPAGTrrYYFDY 2
1G1 #4 IgG2c V5-17 J3 7/6 ARNYYVNrrGFAY 2
1G5 #5 IgG2c V5-17 J3 8/6 TSrQLrLrrVAY 4
3F12 #6 IgG3 V1-26 J3 3/2 TRKGWDDAY 0
Orange shaded, recurrent VH gene; blau coloured, arginine residues in CDR3.
aClonally related hybridomas as defined by identical VH, D, and JH usage, identical CDR3 length and >95% nucleotide identity in CDR3.
bCDR3 as defined by IMGT (37).
cCDR3 as defined by Kabat et al. (38).
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Notably, TFH cell are significantly expanded already in young 
double-knockout mice (Figure  4C). The frequency of IFN-γ 
producing CD4+ T  cells was elevated in both single-knockout 
strains of older age and strongly elevated in older double-
knockout animals (Figure 4D). Thus, early expansion of TFH cells 
in the spleen correlates with the enhanced spontaneous germinal 
center development and high-level IgG anti-dsDNA production 
in double-deficient mice.
DiscUssiOn
The results described in this study reveal a strong genetic interac-
tion of two individual susceptibility genes for anti-dsDNA autoan-
tibody production in SLE that have been described in familiar 
lupus, as well as in knockout mouse models. Null mutations in the 
DNASE1L3 gene were described in familial forms of SLE in Saudi 
Arabia, Turkey, and Italy (19–21). Anti-dsDNA autoantibodies 
were observed in almost all of the cases reported. In addition, a 
potentially defunctioning missense SNP present in relatively high 
frequency in the Caucasian population (40) shows a very high 
association with anti-centromere antibody-positive systemic 
sclerosis (41). For FCGR2B a SNP with considerable variation in 
frequency among human populations results in threonine replac-
ing isoleucine in the transmembrane domain of the receptor (15). 
This causes the variant receptor to be excluded from sphingolipid 
rafts, resulting in a malfunctioning receptor (15). As both SNPs 
have a relatively high frequency within the Caucasian and Asian 
population (the missense SNP in Dnase1l3 is rare among popula-
tions with African origin3), we consider it highly worthwhile to 
analyze the frequency of these two variations among SLE patients. 
Current GWAS studies can explain only a minority of the herit-
ability of complex diseases, a phenomenon that has been termed 
missing heritability (42). Epistatic interactions would be difficult 
to detect in GWAS studies because of computational challenges 
and low statistical power (43). We are currently analyzing such 
a possible epistatic interaction of Dnase1l3 and FcγRIIB in a 
German/French SLE cohort from the upper Rhine.
3 http://phase3browser.1000genomes.org (Accessed: February 15, 2018).
FigUre 4 | Early expansion of T follicular helper (TFH) cells and elevated levels of neutrophils in older Dnase1l3 and FcgR2b double-deficient mice. (a) Analysis of 
the expansion of Ly6G-positive neutrophils in the spleen of young (8–9 weeks old) and older (14–19 weeks old) mice. The genotypes of the mice are denoted at the 
axis. In (B), activation of the CD4+ T cell compartment is displayed by the frequency of CD44hi CD4 cells. (c) Analysis of the expansions of PD1hi PSGL-1lo TFH cells. 
In (D), the frequency of IFN-γ producing CD4+ T cells is displayed. As an example for each analysis, a density plot is shown for wild-type and double-deficient mice. 
Blue circles specifically highlight male mice, red circles represent female mice (*p < 0.05; **p < 0.01; Mann–Whitney U test).
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In our analysis of cohorts of double-mutant mice, we also 
introduced the yaa allele that results in a TLR7 gene-duplication 
(44, 45). The analysis of female double-mutant mice and male 
double-mutant carrying the yaa mutation clearly revealed an 
influence of yaa on the penetrance of development of high levels 
of anti-dsDNA antibodies very early. Only approximately 50% of 
female mice developed high levels of anti-dsDNA antibodies at 
the age of 13 weeks. This is in accordance with the notion that yaa 
accelerates systemic autoimmunity as a genetic modifier in a con-
text of a coexisting SLE background (44, 46). Also, the penetrance 
of early hyperactivation of germinal centers is much lower in 
female double-deficient mice, consistent with the described role 
of the yaa allele for defective germinal center selection in SLE 
(47). Importantly, double-deficient yaa male mice at the age of 
3 months showed about 40 times higher anti-dsDNA levels when 
compared to FcγRIIb−/− yaa male mice of the same age.
Double-mutant mice showed a hyperactivation of spontane-
ously developing germinal centers which correlates with an early 
expansion of TFH cells in the spleen. Expansions of TFH cells were 
first noted in sanroque mutant mice with a lupus-like disease and 
autoantibody production (48) and later also in some SLE patients 
with severe disease (49). As TFH cells are essential for germinal center 
responses (50), our findings here in the context of two epistatically 
acting mutations in the C57BL/6 genetic background further 
strengthen the model that dysregulated germinal center reactions 
are crucially involved in the early phases of the generation of IgG 
anti-dsDNA autoantibodies and the development of SLE (35, 50).
In FcγRIIB-deficient mice, an increase in anti-DNA reactive 
GC B cells was observed and somatic mutations contributed to the 
generation of highly autoreactive IgG antibodies (13). Opposite 
to the findings in single Fcgr2b-deficient mice, however, we 
observed clonal expansions of anti-DNA reactive B cells as well as 
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concomitant expansion of anti-DNA plasmablasts or plasma cells. 
These combined observations prompt a further development of 
our model of the evolution of anti-DNA autoantibodies in germi-
nal centers (35). FcγRIIB and potentially other negative regulators 
for B cell signaling (51) might play a major role in the regulation 
of autoreactive GC B cells which otherwise would develop from 
non-self-reactive or low-level self-reactive precursors by somatic 
mutations (34). We now propose that the deficiency to eliminate 
nuclear material would drive such autoreactive B cell from the 
germinal center into clonal expansion and plasma cell differentia-
tion, presumably outside of the germinal center. Our sequence 
analysis points in the direction that these B cells mutated only 
for limited periods of time. The “bush-like” diversification by 
somatic hypermutation from a single B cell rather than a step-
wise maturation with intermediate selection is compatible with 
this model. Similar “bush-like” genealogies were also observed 
in SLE-prone mice (52, 53). An extraordinary high content of 
arginine residues in the CDR3 region of the heavy chain, which 
is also observed in our study here, apparently is a very common 
prerequisite for such an evolution of anti-dsDNA antibodies (39). 
Recent work attributed removal of apoptotic microparticles from 
the circulation as a major role of Dnase1l3 to prevent loss of toler-
ance to chromatin (22). We suggest an alternative explanation 
which is mutually not exclusive and might operate at local sites, 
particularly in the liver, the spleen, and lymph nodes. We found 
the highest levels of Dnase1l3 expression in cells with excellent 
antigen-presenting competence, high expression of scavenging 
receptors and TLRs, i.e., DCs and Kupffer cells in the liver. Local 
secretion of Dnase1l3 might function as a kind of shield to prevent 
these cells from being activated by damage-associated molecular 
patterns via TLRs and other receptors (54, 55).
In the same direction, local Dnase1l3 secretion might eliminate 
or lower the activation of DCs after uptake of DNA-containing 
immune complexes via Fc receptors which has the potential to 
trigger maturation and interferon production of DCs (17). Under 
non-inflammatory conditions, the inhibitory FcγRIIB would 
dominate activating signals from activating Fcγ receptors on 
DCs (17), however. This could reflect the situation in our single 
Dnase1l3-deficient mouse, in which anti-dsDNA production is 
stalled at relatively moderate levels. When FcγRIIB is blocked on 
human DCs, high levels of IL-12p70 can be induced when anti-
body coated tumor cells are delivered to the DCs (56) and type I 
interferon is induced after delivery of immune complexes to DCs 
(57). This scenario might explain the phenotype of Dnase1l3/
FcγRIIB double-deficient animals described here. Under these 
circumstances, any DNA-containing immune complex could 
potentially trigger DC maturation and production of type I inter-
feron and stimulate TH1 driven responses. A self-perpetuating 
feedback loop would result when anti-dsDNA autoantibodies 
have evolved in such a scenario (58). For the initial trigger, IgG 
anti-dsDNA antibodies are not an essential content in the stimu-
lating immune complexes. Pathogen-derived DNA together with 
pathogen-specific antibodies would be sufficient for starting such 
a DC-initiated self-perpetuating feedback loop.
Our conditional Dnase1l3 allele as well as conditional deletion 
of FcγRIIB will allow the detailed analysis of the cell types that 
are essential for the protection against uncontrolled evolution 
of anti-dsDNA autoantibodies in germinal centers. Potentially, 
comprehensive understanding of this regulation might allow the 
development of new targeted therapies for SLE.
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